Chromosomal abnormalities in venezuelan people with multiple myeloma;Anomalías cromosómicas en pacientes venezolanos con mieloma múltiple

Investigacion Clinica

Volumn 44, Issue 4, 2003, Pages 327-335

  Quintero, Maribel ^a   Rojas Atencio, Alicia ^a   Ruiz, Ana ^a   González, Maczy ^a   Herrera, Jorge ^a   Atencio, Fátima ^a   Delgado, Wilmer ^a   Urdaneta, Karelis ^a   Pérez, Frankie ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Chromosomal abnormalities; Cytogenetics; Multiple myeloma

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 3; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIPLOIDY; FEMALE; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; MULTIPLE MYELOMA; PROGNOSIS; TRIPLOIDY; VENEZUELA; X CHROMOSOME; Y CHROMOSOME;

CHROMOSOME ABERRATIONS; HUMANS; KARYOTYPING; MIDDLE AGED; MULTIPLE MYELOMA; VENEZUELA;

EID: 0742305782     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Beutler E, Coller B, Seligson U, Lichtman M, Kipps T. Williams Hematology. 6ta Ed. Estados Unidos de América: McGraw - Hill Medical Publising; 2001, p 1279-1291.
2. Lee R, Lukens J, Greer J, Foerster J, Paraskevas F, Rodgers G. Wintrobe's Clinical Hematology. 10ma Ed. Estados Unidos: Editorial Williams & Wilkins; 1999, p 2631-2655.
3. Sans-Sabrafen J, Besses Raebel C, Vives Corrons J. Hematología Clínica. 4ta Ed. España: Ediciones Harcourt, S.A.; 2001, p 574-579.
4. Durie B. The epidemiology of multiple myeloma. Semin Hematol 2001; 38: 1-10.
5. Rooney D, Czepulkowski B. Human Citogenetics. A Practical Approach. 2da Ed. Estados Unidos de América: Series Editors: D. Rickwood y B. D. Hames; 1992, p 121-151.
6. Gutiérrez NC, Hernandez J, Garcia J, Almeida J, Mateo G, González M, Hernandez J, Hernandez-Calvo J, San Miguel J. Correlation between cytogenetic abnormalities and disease characteristic in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells. Haematologica 2000; 85:1146-1152.
7. Rojas-Atencio A, Pineda L, González S, Soto M, Avila E, Urdaneta B, Prieto-Carrasquero M, González R. Anomalías cromosómicas en enfermedades hematológicas malignas. Acta Cient Venez 2000; 51:109-114.
8. Yunis J. New chromosome techniques in the study of human neoplasia. Hum Pathol 1981; 12:540-549
9. Bernard J. Diagnóstico y tratamiento clínico por el laboratorio. 7ma Ed. España: Todd Sanford Davidsohn, Salvat Editores; 1984, p 1279-1291.
10. Barch M, Knutsen T, Spurbeek J. The AGT Citogenetics Laboratory Manual. 3ra Ed. Estados Unidos: Lippincott - Raven Publishers; 1997, p 269-336.
11. Mitelman F. An International System for Human Cytogenetics Nomenclature. S. Karger, Basel. ISCN 1995.
12. Avet-Loiseau H, Facon T, Godon C, Rapp MJ, Harousseau JL Grosbois B. 14q32 translocations and monosomy 13 observed in monoclonal gammapathy of undetermined significance delineated multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome. Cancer Res 1999, 59:4546-4550
13. Salamanca F. Citogenética Humana. México: Editorial Médica Panamericana; 1993, p 235-254.
14. Dewald GW, Kyle RA, Hicks GA, Gresp PR. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidoisis. Blood 1985; 66:380-390.
15. Sawyer J, Waldron J, Jagannath S, Barlogie B. Cytogenetics findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 1995; 82:41-49.
16. Barlogie B Jr, Shaughnessy JD. Early results of total therapy II in multiple myeloma: Implication of cytogenetics and FISH. Int J Hematol 2002; 1:137-139.
17. Cigudosa J, Calasanz M, Odero M, Prosper F, Etxaniz A, Marin J, Rifon J, Gullon A, Rocha E. Cytogenetics data in 41 patients with multiple myeloma. Karyotype and other clinical parameters. Cancer Genet Cytogenet 1994; 78:210-213.
18. Ankathil R, Madhavan J, Gangadharan V, Rajasekharan Pillai G, Krisman NM. Non-random karyotype abnormalities in 36 multiple myeloma patients. Cancer Gene Cytogenet 1995; 83:71-74.
19. Zandecki M, Lai JL, Facon T. Multiple myeloma; almost all patients are cytogenetically abnormal. Br J Haematol 1996, 94:217-227.
20. Nilsson T, Lenhoff S, Turesson I, Rylander L, Mitelman F, Westin J, Hoglund M, Johansson B. Cytogenetic features of multiple myeloma: Impact of gender, age, disease phase, culture time and cytokine stimulation. Eur J Haematol 2002; 68:345-353.
21. Johanson B, Mertens F, Mitelman F. Geographic heterogeneity of neoplasia associated chromosome aberration. Genes Chrom Cancer 1991; 3:1-7.
22. Chan L, Kwong Y, Liu H, Chan T, Tod D, Ching M. Cytogenetics analysis of hematological malignancies in Hong Kong. Cancer Genet Cytogenet 1994; 62:154-159.
23. Zandecki M, Bernardi F, Luc La J, Facon T, Izydorezyk V, Bauters f, Cosson A. Image analysis in multiple myeloma at diagnosis. Correlation with cytogenetic study. Cancer Genet Cytogenet 1994; 74:115-119.
24. Durie BG. The biology of multiple myeloma. Hematol Oncol 1988; 6:77-81.
25. Gould J, Goodacre A, Pathak S, Hecht B, Barlogie B. Plasma cell karyotype in multiple myeloma. Blood 1998, 71:453-456.
26. Avet-Loiseau H, Daviet A, Brigaudeau C, Callet E, Terré Ch, Lafage M, Desangles F, Ramond S, Talmant P, Bataille R. Cytogenetic, interphase, and multicolor in situ analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the intergroupe Francophome du Myélome and the groupe francais de cytogenétique Hématologique. Blood 2001; 67:3 822-825.
27. Clark RE, Geddes AD, Whittaker JA, Jacobs A. Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma. Eur J Cancer Clin Oncol 1989, 25:1789-1793
28. Pérez S, García R, Tabernero M, Almeida J, González Fernández J, Moro M, Hernández J, San Miguel J, Orfao A. Pronostic value of numerical chromosome aberration in multiple myeloma: a FISH analysis of is different chromosome. Blood 1998, 91:3366-3371.
29. Seong Ch, Delasalle K, Hayes K, Weber D, Dinopoulos M, Swantkowski J, Hun Y, Glassman A, Chaplin R, Alexanian R. Prognostic value of cytogenetics in multiple myeloma. Br J Haematol 1998; 101:189-194
30. Fassas A, Spencer T, Sawyer J, Zangari, Kee Lee CH, Anaissie E, Muwalla F, Morris Ch, Barlogie B, Tricot G. Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma. Br J Haematol 2002; 118:1041-1045.
31. Konigsberg R, Zoger N, Ackermann J, Kromer e, Kittler H, Fritz E, Kaufmann H, Noslinger T, Rield L, Gisslinger H, Jager U, Simonitsch I, Heinz R, Heinz I, Heinz H, Drach J. Predictive role of interphase cytogenetics for survival of patiens with multiple myeloma. J Clin Oncol 2000; 18:804-812.
32. Schreiber S, Ackermann J, Obermair A, Kaufmann H, Urbauer E, Aletaha K, Gisslinger H, Chott A, Huber H, Drach J. Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization. Br J Haematol 2000; 110:605-609.
33. Joy Ho P. Chromosomal and genetic abnormalities in myeloma. Clin Lab Haematol 2002, 24:259-269.